Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain langauage summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Restoring value to stalled Phase II compounds: the case for developing a novel compound for depression using pharmacogenetics, Pharmacogenomics, March 2005, Future Medicine, DOI: 10.1517/14622416.6.2.95.
You can read the full text:

Read

Contributors

The following have contributed to this page